1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR
50.22 -0.84 (-1.65%)
4.7M
XNYS Volume

XNYS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Acquisition
GSK to acquire Chimagen's experimental blood cancer drug in deal worth up to $750 million See details

GSK PLC (ADR) RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

GSK PLC (ADR) technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis